European Commission Approves DARZALEX (daratumumab)-SC Quadruplet Regimen for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Read more
Lilly’s Kisunla Gains Marketing Authorization in Great Britain for Alzheimer’s Treatment in Select Adult Patients Read more
Exelixis and Merck Partner to Advance Zanzalintinib Trials with KEYTRUDA in Head and Neck Cancer and WELIREG in Renal Cell Carcinoma Read more
Enhertu Gains Approval in China as First HER2-Directed Therapy for HER2-Mutant Metastatic Non-Small Cell Lung Cancer Read more
FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Read more
Boehringer Ingelheim and Circle Pharma announce new research collaboration to develop a novel precision cancer treatment Read more
Boehringer receives FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide Read more